Nephrolithiasis in patients with inflammatory bowel disease in the community

International Journal of Nephrology and Renovascular Disease

Volumn 6, Issue , 2013, Pages 139-142

  Bismara Cury, Dídia ^a,b   Moss, Alan C ^b   Schor, Nestor ^c  

^a Scope Clinic   (Brazil)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical activity indices; Crohn's disease; Inflammatory bowel disease; Nephrolithiasis; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDY; RECURRENT INFECTION; SCREENING TEST; SYMPTOMATOLOGY; ULCERATIVE COLITIS; ULTRASOUND; URINARY TRACT INFECTION;

EID: 84880930483     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S45466     Document Type: Article

References (14)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-11823.
2. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833-838.
3. Clark JY, Thompson IM, Optenberg SA. Economic impact of urolithiasis in the United States. J Urol. 1995;154(6):2020-2024.
4. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004;164(8):885-891.
5. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003;63(1):255-265.
6. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003;64(6):2204-2213.
7. Kumar R, Ghoshal UC, Singh G, Mittal RD. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation. J Gastroenterol Hepatol. 2004;19(12):1403-1409.
8. Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol. 2009;4(3):680-684.
9. Van Assche G, Vermeire S, Rutgeerts P. The potential for disease modification in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2010;7(2):79-85.
10. Andersson H, Bosaeus I, Fasth S, Hellberg R, Hulten L. Cholelithiasis and urolithiasis in Crohn's disease. Scand J Gastroenterol. 1987;22(2):253-256.
11. Cirillo M, Iudici M, Marcarelli F, Laudato M, Zincone F. Nephrolithiasis in patients with intestinal diseases. G Ital Nefrol. 2008;25(1):42-48.Italian.
12. Jin DH, Lamberton GR, Broome DR, et al. Effect of reduced radiation CT protocols on the detection of renal calculi. Radiology. 2010;255(1):100-107.
13. Mugiya S. Guidelines on urolithiasis: update of diagnosis and treatment. Hinyokika Kiyo. 2012;58(12):703-706.Japanese.
14. Viana ML, Pontes RM, Garcia WE, Favero ME, Prete DC, Matsuo T. Crohn's disease and kidney stones: much more than coincidence? Arq Gastroenterol. 2007;44(3):210-214.